Jaculus jaculus isolate mJacJac1 chromosome 18, mJacJac1.mat.Y.cur, whole genome shotgun sequence.
Jaculus jaculus (lesser Egyptian jerboa)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Dipodoidea; Dipodidae; Dipodinae; Jaculus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036406.1.\nAssembly name: mJacJac1.mat.Y.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSA000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 2021\nAssembly Method :: Trio HiCanu v. 2.1; purge_dups v. 1.2.3;\n Scaff10x v. 4.2; Bionano Solve v. 3.5.1;\n bwa v. 0.7.17; gcpp v. 1.9.0; Longranger\n Align v. 2.2.2; Freebayes v. 1.3.2; gEVAL\n manual curation v. 2021-05--07\nAssembly Name :: mJacJac1.mat.Y.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 61.0x\nSequencing Technology :: PacBio Sequel II CLR 101X; 10X Gemonics\n linked reads 78X; Bionano Genomics DLS\n 182X; Arima Genomics Hi-C v1 60X\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Jaculus jaculus Annotation Release\n 102\nAnnotation Version :: 102\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
protocadherin related 15, transcript variant X4
COORDINATES: polyA evidence [ECO:0006239]
protocadherin related 15, transcript variant X2
protocadherin related 15, transcript variant X3
protocadherin related 15, transcript variant X1
protocadherin related 15, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
peptidyl-prolyl cis-trans isomerase NIMA-interacting 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CDGSH iron-sulfur domain-containing protein 1
ubiquitin conjugating enzyme E2 D1, transcript variant X1
ubiquitin-conjugating enzyme E2 D1 isoform X1
ubiquitin conjugating enzyme E2 D1, transcript variant X2
ubiquitin-conjugating enzyme E2 D1 isoform X2
BicC family RNA binding protein 1, transcript variant X1
BicC family RNA binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
BicC family RNA binding protein 1, transcript variant X3
phytanoyl-CoA 2-hydroxylase interacting protein like, transcript variant X2
phytanoyl-CoA 2-hydroxylase interacting protein like, transcript variant X1
phytanoyl-CoA hydroxylase-interacting protein-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
phytanoyl-CoA hydroxylase-interacting protein-like isoform X2
family with sequence similarity 13 member C, transcript variant X4
family with sequence similarity 13 member C, transcript variant X6
family with sequence similarity 13 member C, transcript variant X3
family with sequence similarity 13 member C, transcript variant X2
family with sequence similarity 13 member C, transcript variant X1
family with sequence similarity 13 member C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 16 member 9, transcript variant X2
solute carrier family 16 member 9, transcript variant X1
monocarboxylate transporter 9 isoform X2
monocarboxylate transporter 9 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
Rho related BTB domain containing 1, transcript variant X1
Rho related BTB domain containing 1, transcript variant X7
Rho related BTB domain containing 1, transcript variant X2
Rho related BTB domain containing 1, transcript variant X3
Rho related BTB domain containing 1, transcript variant X8
Rho related BTB domain containing 1, transcript variant X5
Rho related BTB domain containing 1, transcript variant X4
rho-related BTB domain-containing protein 1 isoform X1
rho-related BTB domain-containing protein 1 isoform X3
rho-related BTB domain-containing protein 1 isoform X2
rho-related BTB domain-containing protein 1 isoform X5
Rho related BTB domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rho-related BTB domain-containing protein 1 isoform X4
Rho related BTB domain containing 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rho-related BTB domain-containing protein 1 isoform X6
transmembrane protein 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane protein 26, transcript variant X2
ciliary associated calcium binding coiled-coil 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ciliary associated calcium binding coiled-coil 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ciliary-associated calcium-binding coiled-coil protein 1 isoform X1
ciliary-associated calcium-binding coiled-coil protein 1 isoform X2
ciliary associated calcium binding coiled-coil 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ciliary-associated calcium-binding coiled-coil protein 1 isoform X3
AT-rich interaction domain 5B, transcript variant X1
AT-rich interactive domain-containing protein 5B isoform X1
AT-rich interaction domain 5B, transcript variant X2
AT-rich interactive domain-containing protein 5B isoform X2
AT-rich interaction domain 5B, transcript variant X3
AT-rich interactive domain-containing protein 5B isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 365, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 365, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 365, transcript variant X1
zinc finger protein 365, transcript variant X3
zinc finger protein 365, transcript variant X2
early growth response 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
early growth response 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear receptor binding factor 2, transcript variant X1
nuclear receptor-binding factor 2 isoform X1
nuclear receptor binding factor 2, transcript variant X2
nuclear receptor-binding factor 2 isoform X2
jumonji domain containing 1C, transcript variant X3
jumonji domain containing 1C, transcript variant X2
jumonji domain containing 1C, transcript variant X1
probable JmjC domain-containing histone demethylation protein 2C isoform X1
probable JmjC domain-containing histone demethylation protein 2C isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
polyadenylate-binding protein-interacting protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 3% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
leucine rich repeat transmembrane neuronal 3
leucine-rich repeat transmembrane neuronal protein 3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DnaJ heat shock protein family (Hsp40) member C12
NAD-dependent protein deacetylase sirtuin-1 isoform X1
NAD-dependent protein deacetylase sirtuin-1 isoform X2
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X4
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X2
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X7
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X5
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X1
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X3
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X6
probable E3 ubiquitin-protein ligase HERC4 isoform X4
probable E3 ubiquitin-protein ligase HERC4 isoform X2
probable E3 ubiquitin-protein ligase HERC4 isoform X1
probable E3 ubiquitin-protein ligase HERC4 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
phenazine biosynthesis like protein domain containing
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phenazine biosynthesis-like domain-containing protein
heterogeneous nuclear ribonucleoprotein H3, transcript variant X2
heterogeneous nuclear ribonucleoprotein H3, transcript variant X1
heterogeneous nuclear ribonucleoprotein H3, transcript variant X3
heterogeneous nuclear ribonucleoprotein H3, transcript variant X4
heterogeneous nuclear ribonucleoprotein H3 isoform X1
heterogeneous nuclear ribonucleoprotein H3 isoform X2
heterogeneous nuclear ribonucleoprotein H3 isoform X3
RUN and FYVE domain containing 2, transcript variant X3
RUN and FYVE domain containing 2, transcript variant X5
RUN and FYVE domain containing 2, transcript variant X2
RUN and FYVE domain containing 2, transcript variant X1
RUN and FYVE domain containing 2, transcript variant X4
RUN and FYVE domain-containing protein 2 isoform X3
RUN and FYVE domain-containing protein 2 isoform X2
RUN and FYVE domain-containing protein 2 isoform X1
RUN and FYVE domain-containing protein 2 isoform X4
RUN and FYVE domain containing 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RUN and FYVE domain containing 2, transcript variant X6
RUN and FYVE domain-containing protein 2 isoform X5
DNA replication helicase/nuclease 2, transcript variant X1
DNA replication helicase/nuclease 2, transcript variant X2
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X1
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X2
solute carrier family 25 member 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 25 member 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
graves disease carrier protein isoform X1
graves disease carrier protein isoform X2
tet methylcytosine dioxygenase 1, transcript variant X1
tet methylcytosine dioxygenase 1, transcript variant X2
methylcytosine dioxygenase TET1 isoform X1
methylcytosine dioxygenase TET1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell division cycle and apoptosis regulator 1, transcript variant X1
cell division cycle and apoptosis regulator 1, transcript variant X2
cell division cycle and apoptosis regulator protein 1 isoform X1
cell division cycle and apoptosis regulator protein 1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00607
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
DExD-box helicase 50, transcript variant X1
DExD-box helicase 50, transcript variant X2
ATP-dependent RNA helicase DDX50 isoform X1
ATP-dependent RNA helicase DDX50 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
VPS26, retromer complex component A, transcript variant X1
vacuolar protein sorting-associated protein 26A isoform X1
VPS26, retromer complex component A, transcript variant X2
vacuolar protein sorting-associated protein 26A isoform X2
ATP-dependent RNA helicase SUPV3L1, mitochondrial
hexokinase domain containing 1, transcript variant X1
hexokinase domain containing 1, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00322
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins
ubiquitin-40S ribosomal protein S27a-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00438
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
family with sequence similarity 241 member B
collagen type XIII alpha 1 chain, transcript variant X17
collagen type XIII alpha 1 chain, transcript variant X2
collagen type XIII alpha 1 chain, transcript variant X1
collagen type XIII alpha 1 chain, transcript variant X3
collagen type XIII alpha 1 chain, transcript variant X6
collagen type XIII alpha 1 chain, transcript variant X5
collagen type XIII alpha 1 chain, transcript variant X10
collagen type XIII alpha 1 chain, transcript variant X12
collagen type XIII alpha 1 chain, transcript variant X11
collagen type XIII alpha 1 chain, transcript variant X4
collagen type XIII alpha 1 chain, transcript variant X18
collagen type XIII alpha 1 chain, transcript variant X9
collagen type XIII alpha 1 chain, transcript variant X8
collagen type XIII alpha 1 chain, transcript variant X19
collagen type XIII alpha 1 chain, transcript variant X7
collagen type XIII alpha 1 chain, transcript variant X20
collagen alpha-1(XIII) chain isoform X17
collagen alpha-1(XIII) chain isoform X10
collagen alpha-1(XIII) chain isoform X12
collagen alpha-1(XIII) chain isoform X11
collagen alpha-1(XIII) chain isoform X18
collagen alpha-1(XIII) chain isoform X19
collagen alpha-1(XIII) chain isoform X20
collagen type XIII alpha 1 chain, transcript variant X13
collagen type XIII alpha 1 chain, transcript variant X16
collagen alpha-1(XIII) chain isoform X13
collagen alpha-1(XIII) chain isoform X16
collagen type XIII alpha 1 chain, transcript variant X14
collagen type XIII alpha 1 chain, transcript variant X15
collagen alpha-1(XIII) chain isoform X14
collagen alpha-1(XIII) chain isoform X15
apoptosis inducing factor mitochondria associated 2
trypsin like peroxisomal matrix peptidase 1, transcript variant X2
trypsin like peroxisomal matrix peptidase 1, transcript variant X1
peroxisomal leader peptide-processing protease isoform X2
peroxisomal leader peptide-processing protease isoform X1
trypsin like peroxisomal matrix peptidase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
peroxisomal leader peptide-processing protease isoform X3
secretion associated Ras related GTPase 1A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
leucine rich repeat containing 20, transcript variant X2
leucine rich repeat containing 20, transcript variant X1
leucine-rich repeat-containing protein 20
eukaryotic translation initiation factor 4E binding protein 2
eukaryotic translation initiation factor 4E-binding protein 2
phosphatase domain containing paladin 1, transcript variant X3
phosphatase domain containing paladin 1, transcript variant X2
phosphatase domain containing paladin 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif 14, transcript variant X1
ADAM metallopeptidase with thrombospondin type 1 motif 14, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 14 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 14 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
sphingosine-1-phosphate lyase 1, transcript variant X3
sphingosine-1-phosphate lyase 1, transcript variant X1
sphingosine-1-phosphate lyase 1, transcript variant X2
pterin-4 alpha-carbinolamine dehydratase 1
pterin-4-alpha-carbinolamine dehydratase
unc-5 netrin receptor B, transcript variant X1
unc-5 netrin receptor B, transcript variant X2
uncharacterized protein C10orf105 homolog
V-set immunoregulatory receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
V-set immunoregulatory receptor, transcript variant X3
V-set immunoregulatory receptor, transcript variant X1
V-type immunoglobulin domain-containing suppressor of T-cell activation isoform X2
V-type immunoglobulin domain-containing suppressor of T-cell activation isoform X1
ATP synthase subunit d, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
eukaryotic translation initiation factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: eukaryotic translation initiation factor 1
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2, transcript variant X1
activating signal cointegrator 1 complex subunit 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
activating signal cointegrator 1 complex subunit 1, transcript variant X2
activating signal cointegrator 1 complex subunit 1, transcript variant X1
activating signal cointegrator 1 complex subunit 1, transcript variant X3
activating signal cointegrator 1 complex subunit 1
DNA damage-inducible transcript 4 protein
DnaJ heat shock protein family (Hsp40) member B12, transcript variant X1
DnaJ heat shock protein family (Hsp40) member B12, transcript variant X3
DnaJ heat shock protein family (Hsp40) member B12, transcript variant X2
dnaJ homolog subfamily B member 12 isoform X1
dnaJ homolog subfamily B member 12 isoform X2
mitochondrial calcium uptake 1, transcript variant X2
mitochondrial calcium uptake 1, transcript variant X1
calcium uptake protein 1, mitochondrial isoform X2
calcium uptake protein 1, mitochondrial isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00398
calcium uniporter protein, mitochondrial
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
oncoprotein-induced transcript 3 protein
phospholipase A2 group XIIB, transcript variant X3
phospholipase A2 group XIIB, transcript variant X2
phospholipase A2 group XIIB, transcript variant X1
group XIIB secretory phospholipase A2-like protein isoform X3
group XIIB secretory phospholipase A2-like protein isoform X2
group XIIB secretory phospholipase A2-like protein isoform X1
prolyl 4-hydroxylase subunit alpha 1, transcript variant X2
prolyl 4-hydroxylase subunit alpha 1, transcript variant X1
prolyl 4-hydroxylase subunit alpha-1 isoform X2
prolyl 4-hydroxylase subunit alpha-1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
nudix hydrolase 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
nudix hydrolase 13, transcript variant X2
NAD(P)H pyrophosphatase NUDT13, mitochondrial isoform X1
NAD(P)H pyrophosphatase NUDT13, mitochondrial isoform X2
ecdysoneless cell cycle regulator, transcript variant X2
ecdysoneless cell cycle regulator, transcript variant X1
family with sequence similarity 149 member B1, transcript variant X1
primary cilium assembly protein FAM149B1 isoform X1
family with sequence similarity 149 member B1, transcript variant X3
family with sequence similarity 149 member B1, transcript variant X2
primary cilium assembly protein FAM149B1 isoform X2
DnaJ heat shock protein family (Hsp40) member C9
28S ribosomal protein S16, mitochondrial
cilia and flagella associated protein 70
cilia- and flagella-associated protein 70
MSS51 mitochondrial translational activator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
putative protein MSS51 homolog, mitochondrial
protein phosphatase 3 catalytic subunit beta, transcript variant X4
protein phosphatase 3 catalytic subunit beta, transcript variant X3
protein phosphatase 3 catalytic subunit beta, transcript variant X2
protein phosphatase 3 catalytic subunit beta, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1
ubiquitin specific peptidase 54, transcript variant X11
ubiquitin specific peptidase 54, transcript variant X9
ubiquitin specific peptidase 54, transcript variant X5
ubiquitin specific peptidase 54, transcript variant X8
ubiquitin specific peptidase 54, transcript variant X7
ubiquitin specific peptidase 54, transcript variant X14
ubiquitin specific peptidase 54, transcript variant X4
ubiquitin specific peptidase 54, transcript variant X1
ubiquitin specific peptidase 54, transcript variant X10
ubiquitin specific peptidase 54, transcript variant X6
ubiquitin specific peptidase 54, transcript variant X2
ubiquitin specific peptidase 54, transcript variant X3
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X9
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X8
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X7
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X4
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X3
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X6
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X5
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X11
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X2
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X1
ubiquitin specific peptidase 54, transcript variant X12
ubiquitin specific peptidase 54, transcript variant X13
inactive ubiquitin carboxyl-terminal hydrolase 54 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: synaptopodin 2-like protein
SEC24 homolog C, COPII coat complex component, transcript variant X2
SEC24 homolog C, COPII coat complex component, transcript variant X1
SEC24 homolog C, COPII coat complex component, transcript variant X5
SEC24 homolog C, COPII coat complex component, transcript variant X3
SEC24 homolog C, COPII coat complex component, transcript variant X4
protein transport protein Sec24C isoform X1
protein transport protein Sec24C isoform X2
uncharacterized LOC123455752, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123455752, transcript variant X4
uncharacterized LOC123455752, transcript variant X3
uncharacterized LOC123455752, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
coiled-coil-helix-coiled-coil-helix domain containing 1
coiled-coil-helix-coiled-coil-helix domain-containing protein 1
zinc finger SWIM-type containing 8, transcript variant X5
zinc finger SWIM-type containing 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger SWIM-type containing 8, transcript variant X3
zinc finger SWIM-type containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger SWIM-type containing 8, transcript variant X4
zinc finger SWIM domain-containing protein 8 isoform X5
zinc finger SWIM domain-containing protein 8 isoform X1
zinc finger SWIM domain-containing protein 8 isoform X3
zinc finger SWIM domain-containing protein 8 isoform X2
zinc finger SWIM domain-containing protein 8 isoform X4
N-deacetylase and N-sulfotransferase 2, transcript variant X1
N-deacetylase and N-sulfotransferase 2, transcript variant X2
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 isoform X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 isoform X2
calcium/calmodulin dependent protein kinase II gamma, transcript variant X6
calcium/calmodulin dependent protein kinase II gamma, transcript variant X18
calcium/calmodulin dependent protein kinase II gamma, transcript variant X15
calcium/calmodulin dependent protein kinase II gamma, transcript variant X8
calcium/calmodulin dependent protein kinase II gamma, transcript variant X17
calcium/calmodulin dependent protein kinase II gamma, transcript variant X11
calcium/calmodulin dependent protein kinase II gamma, transcript variant X13
calcium/calmodulin dependent protein kinase II gamma, transcript variant X4
calcium/calmodulin dependent protein kinase II gamma, transcript variant X12
calcium/calmodulin dependent protein kinase II gamma, transcript variant X3
calcium/calmodulin dependent protein kinase II gamma, transcript variant X14
calcium/calmodulin dependent protein kinase II gamma, transcript variant X5
calcium/calmodulin dependent protein kinase II gamma, transcript variant X9
calcium/calmodulin dependent protein kinase II gamma, transcript variant X1
calcium/calmodulin dependent protein kinase II gamma, transcript variant X2
calcium/calmodulin dependent protein kinase II gamma, transcript variant X7
calcium/calmodulin dependent protein kinase II gamma, transcript variant X10
calcium/calmodulin dependent protein kinase II gamma, transcript variant X16
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X18
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X16
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X10
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X7
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X2
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X6
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X15
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X8
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X17
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X11
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X13
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X4
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X12
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X3
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X14
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X5
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X9
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1
calcium/calmodulin dependent protein kinase II gamma, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X19
adaptor related protein complex 3 subunit mu 1, transcript variant X1
adaptor related protein complex 3 subunit mu 1, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: lysophospholipase D GDPD1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
lysine acetyltransferase 6B, transcript variant X2
lysine acetyltransferase 6B, transcript variant X1
lysine acetyltransferase 6B, transcript variant X3
lysine acetyltransferase 6B, transcript variant X4
histone acetyltransferase KAT6B isoform X1
histone acetyltransferase KAT6B isoform X2
histone acetyltransferase KAT6B isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dual specificity protein phosphatase 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
sterile alpha motif domain containing 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sterile alpha motif domain containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sphingomyelin synthase-related protein 1
voltage-dependent anion-selective channel protein 2
catechol-O-methyltransferase domain containing 1
catechol O-methyltransferase domain-containing protein 1
U1 small nuclear ribonucleoprotein 70 kDa-like
leucine rich melanocyte differentiation associated
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich melanocyte differentiation-associated protein
potassium calcium-activated channel subfamily M alpha 1, transcript variant X32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
potassium calcium-activated channel subfamily M alpha 1, transcript variant X30
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
potassium calcium-activated channel subfamily M alpha 1, transcript variant X31
potassium calcium-activated channel subfamily M alpha 1, transcript variant X29
potassium calcium-activated channel subfamily M alpha 1, transcript variant X27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium calcium-activated channel subfamily M alpha 1, transcript variant X26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium calcium-activated channel subfamily M alpha 1, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium calcium-activated channel subfamily M alpha 1, transcript variant X12
potassium calcium-activated channel subfamily M alpha 1, transcript variant X24
potassium calcium-activated channel subfamily M alpha 1, transcript variant X22
potassium calcium-activated channel subfamily M alpha 1, transcript variant X19
potassium calcium-activated channel subfamily M alpha 1, transcript variant X17
potassium calcium-activated channel subfamily M alpha 1, transcript variant X5
potassium calcium-activated channel subfamily M alpha 1, transcript variant X21
potassium calcium-activated channel subfamily M alpha 1, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium calcium-activated channel subfamily M alpha 1, transcript variant X14
potassium calcium-activated channel subfamily M alpha 1, transcript variant X10
potassium calcium-activated channel subfamily M alpha 1, transcript variant X9
potassium calcium-activated channel subfamily M alpha 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium calcium-activated channel subfamily M alpha 1, transcript variant X13
potassium calcium-activated channel subfamily M alpha 1, transcript variant X8
potassium calcium-activated channel subfamily M alpha 1, transcript variant X7
potassium calcium-activated channel subfamily M alpha 1, transcript variant X3
potassium calcium-activated channel subfamily M alpha 1, transcript variant X1
calcium-activated potassium channel subunit alpha-1 isoform X32
calcium-activated potassium channel subunit alpha-1 isoform X30
calcium-activated potassium channel subunit alpha-1 isoform X31
calcium-activated potassium channel subunit alpha-1 isoform X29
calcium-activated potassium channel subunit alpha-1 isoform X27
calcium-activated potassium channel subunit alpha-1 isoform X26
calcium-activated potassium channel subunit alpha-1 isoform X20
calcium-activated potassium channel subunit alpha-1 isoform X12
calcium-activated potassium channel subunit alpha-1 isoform X24
calcium-activated potassium channel subunit alpha-1 isoform X22
calcium-activated potassium channel subunit alpha-1 isoform X19
calcium-activated potassium channel subunit alpha-1 isoform X17
calcium-activated potassium channel subunit alpha-1 isoform X5
calcium-activated potassium channel subunit alpha-1 isoform X21
calcium-activated potassium channel subunit alpha-1 isoform X16
calcium-activated potassium channel subunit alpha-1 isoform X14
calcium-activated potassium channel subunit alpha-1 isoform X10
calcium-activated potassium channel subunit alpha-1 isoform X9
calcium-activated potassium channel subunit alpha-1 isoform X4
calcium-activated potassium channel subunit alpha-1 isoform X13
calcium-activated potassium channel subunit alpha-1 isoform X8
calcium-activated potassium channel subunit alpha-1 isoform X7
calcium-activated potassium channel subunit alpha-1 isoform X3
calcium-activated potassium channel subunit alpha-1 isoform X1
potassium calcium-activated channel subfamily M alpha 1, transcript variant X25
potassium calcium-activated channel subfamily M alpha 1, transcript variant X11
potassium calcium-activated channel subfamily M alpha 1, transcript variant X23
potassium calcium-activated channel subfamily M alpha 1, transcript variant X18
potassium calcium-activated channel subfamily M alpha 1, transcript variant X15
potassium calcium-activated channel subfamily M alpha 1, transcript variant X6
potassium calcium-activated channel subfamily M alpha 1, transcript variant X2
calcium-activated potassium channel subunit alpha-1 isoform X25
calcium-activated potassium channel subunit alpha-1 isoform X11
calcium-activated potassium channel subunit alpha-1 isoform X23
calcium-activated potassium channel subunit alpha-1 isoform X18
calcium-activated potassium channel subunit alpha-1 isoform X15
calcium-activated potassium channel subunit alpha-1 isoform X6
calcium-activated potassium channel subunit alpha-1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
potassium calcium-activated channel subfamily M alpha 1, transcript variant X28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium-activated potassium channel subunit alpha-1 isoform X28
COORDINATES: nucleotide motif:Rfam:12.0:RF00045
discs large MAGUK scaffold protein 5, transcript variant X1
discs large MAGUK scaffold protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
DNA-directed RNA polymerase III subunit RPC1
ribosomal protein S24, transcript variant X4
ribosomal protein S24, transcript variant X2
ribosomal protein S24, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ribosomal protein S24, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ribosomal protein S24, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small nucleolar RNA SNORA30/SNORA37 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00415
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
zinc finger MIZ-type containing 1, transcript variant X3
zinc finger MIZ-type containing 1, transcript variant X1
zinc finger MIZ-type containing 1, transcript variant X2
zinc finger MIZ domain-containing protein 1 isoform X1
zinc finger MIZ domain-containing protein 1 isoform X3
zinc finger MIZ domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
peptidyl-prolyl cis-trans isomerase F, mitochondrial
zinc finger CCHC domain-containing protein 24
placenta associated 9, transcript variant X2
placenta associated 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 254, transcript variant X1
transmembrane protein 254, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
pulmonary surfactant-associated protein D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
pulmonary surfactant-associated protein A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
peroxiredoxin like 2A, transcript variant X3
peroxiredoxin like 2A, transcript variant X4
peroxiredoxin like 2A, transcript variant X2
peroxiredoxin like 2A, transcript variant X1
SH2 domain containing 4B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
SH2 domain containing 4B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
SH2 domain containing 4B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
SH2 domain-containing protein 4B isoform X1
SH2 domain-containing protein 4B isoform X2
SH2 domain-containing protein 4B isoform X3
pro-neuregulin-3, membrane-bound isoform isoform X1
pro-neuregulin-3, membrane-bound isoform isoform X7
pro-neuregulin-3, membrane-bound isoform isoform X4
pro-neuregulin-3, membrane-bound isoform isoform X3
pro-neuregulin-3, membrane-bound isoform isoform X8
pro-neuregulin-3, membrane-bound isoform isoform X5
pro-neuregulin-3, membrane-bound isoform isoform X2
pro-neuregulin-3, membrane-bound isoform isoform X9
pro-neuregulin-3, membrane-bound isoform isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pro-neuregulin-3, membrane-bound isoform isoform X10
growth hormone inducible transmembrane protein
growth hormone-inducible transmembrane protein
leucine rich repeat, Ig-like and transmembrane domains 2
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2
leucine rich repeat, Ig-like and transmembrane domains 1
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1
retinal G protein coupled receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
retinal G protein coupled receptor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 30% coverage of the annotated genomic feature by RNAseq alignments
retinal G protein coupled receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
RPE-retinal G protein-coupled receptor isoform X2
RPE-retinal G protein-coupled receptor isoform X3
RPE-retinal G protein-coupled receptor isoform X1
coiled-coil serine rich protein 2, transcript variant X2
coiled-coil serine rich protein 2, transcript variant X1
coiled-coil serine rich protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coiled-coil serine rich protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine-rich coiled-coil domain-containing protein 2 isoform X1
serine-rich coiled-coil domain-containing protein 2 isoform X3
serine-rich coiled-coil domain-containing protein 2 isoform X2
coiled-coil serine rich protein 2, transcript variant X5
serine-rich coiled-coil domain-containing protein 2 isoform X4
glutamate ionotropic receptor delta type subunit 1, transcript variant X1
glutamate receptor ionotropic, delta-1 isoform X1
glutamate ionotropic receptor delta type subunit 1, transcript variant X2
glutamate receptor ionotropic, delta-1 isoform X2
WAPL cohesin release factor, transcript variant X3
WAPL cohesin release factor, transcript variant X1
WAPL cohesin release factor, transcript variant X2
wings apart-like protein homolog isoform X2
wings apart-like protein homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments
LIM domain binding 3, transcript variant X1
LIM domain binding 3, transcript variant X3
LIM domain binding 3, transcript variant X5
LIM domain binding 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LIM domain binding 3, transcript variant X2
bone morphogenetic protein receptor type 1A
bone morphogenetic protein receptor type-1A
family with sequence similarity 25 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate dehydrogenase 1, mitochondrial
shieldin complex subunit 2, transcript variant X1
shieldin complex subunit 2, transcript variant X3
shieldin complex subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase TRIM39-like isoform X1
E3 ubiquitin-protein ligase TRIM39-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase TRIM39-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
G protein regulated inducer of neurite outgrowth 2, transcript variant X2
G protein regulated inducer of neurite outgrowth 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G protein regulated inducer of neurite outgrowth 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G protein-regulated inducer of neurite outgrowth 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 6% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 488, transcript variant X3
zinc finger protein 488, transcript variant X2
zinc finger protein 488, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
growth differentiation factor 10, transcript variant X2
growth differentiation factor 10, transcript variant X1
growth/differentiation factor 10 isoform X2
growth/differentiation factor 10 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
protein tyrosine phosphatase non-receptor type 20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein phosphatase non-receptor type 20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
FERM and PDZ domain-containing protein 2
mitogen-activated protein kinase 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitogen-activated protein kinase 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mitogen-activated protein kinase 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitogen-activated protein kinase 8 isoform X1
mitogen-activated protein kinase 8 isoform X2
mitogen-activated protein kinase 8 isoform X3
Rho GTPase activating protein 22, transcript variant X4
Rho GTPase activating protein 22, transcript variant X3
Rho GTPase activating protein 22, transcript variant X1
Rho GTPase activating protein 22, transcript variant X2
rho GTPase-activating protein 22 isoform X4
rho GTPase-activating protein 22 isoform X3
rho GTPase-activating protein 22 isoform X1
rho GTPase-activating protein 22 isoform X2
Rho GTPase activating protein 22, transcript variant X5
rho GTPase-activating protein 22 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
WD repeat- and FYVE domain-containing protein 4
leucine rich repeat containing 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine rich repeat containing 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat-containing protein 18
V-set and transmembrane domain containing 4
V-set and transmembrane domain-containing protein 4
family with sequence similarity 170 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 20% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
cardiac-enriched FHL2-interacting protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
ERCC excision repair 6, chromatin remodeling factor, transcript variant X1
ERCC excision repair 6, chromatin remodeling factor, transcript variant X3
ERCC excision repair 6, chromatin remodeling factor, transcript variant X4
ERCC excision repair 6, chromatin remodeling factor, transcript variant X2
transfer RNA arginine (anticodon CCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
oxoglutarate dehydrogenase L, transcript variant X2
oxoglutarate dehydrogenase L, transcript variant X1
2-oxoglutarate dehydrogenase-like, mitochondrial
mitochondrial import inner membrane translocase subunit Tim23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
WASH complex subunit 2C, transcript variant X1
WASH complex subunit 2C, transcript variant X4
WASH complex subunit 2C, transcript variant X5
WASH complex subunit 2C, transcript variant X2
WASH complex subunit 2C, transcript variant X3
WASH complex subunit 2C, transcript variant X6
membrane associated ring-CH-type finger 8, transcript variant X1
membrane associated ring-CH-type finger 8, transcript variant X4
membrane associated ring-CH-type finger 8, transcript variant X2
membrane associated ring-CH-type finger 8, transcript variant X5
E3 ubiquitin-protein ligase MARCHF8 isoform X1
E3 ubiquitin-protein ligase MARCHF8 isoform X4
membrane associated ring-CH-type finger 8, transcript variant X3
E3 ubiquitin-protein ligase MARCHF8 isoform X2
E3 ubiquitin-protein ligase MARCHF8 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
polyunsaturated fatty acid 5-lipoxygenase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins
olfactory receptor 13A1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
olfactory receptor 13A1-like, transcript variant X2
olfactory receptor 13A1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 22, transcript variant X1
zinc finger protein 22, transcript variant X2
Ras association domain family member 4, transcript variant X2
Ras association domain family member 4, transcript variant X1
ras association domain-containing protein 4 isoform X2
ras association domain-containing protein 4 isoform X1
transmembrane protein 72, transcript variant X1
transmembrane protein 72, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
C-X-C motif chemokine ligand 12, transcript variant X2
C-X-C motif chemokine ligand 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
stromal cell-derived factor 1 isoform X2
stromal cell-derived factor 1 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
COORDINATES: nucleotide motif:Rfam:12.0:RF01268
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
zinc finger protein 32, transcript variant X2
zinc finger protein 32, transcript variant X1
zinc finger protein 239, transcript variant X1
zinc finger protein 239, transcript variant X2
heterogeneous nuclear ribonucleoprotein F, transcript variant X1
heterogeneous nuclear ribonucleoprotein F, transcript variant X2
heterogeneous nuclear ribonucleoprotein F, transcript variant X3
heterogeneous nuclear ribonucleoprotein F, transcript variant X4
heterogeneous nuclear ribonucleoprotein F, transcript variant X6
heterogeneous nuclear ribonucleoprotein F, transcript variant X5
heterogeneous nuclear ribonucleoprotein F, transcript variant X7
heterogeneous nuclear ribonucleoprotein F
FXYD domain containing ion transport regulator 4, transcript variant X2
FXYD domain containing ion transport regulator 4, transcript variant X1
FXYD domain-containing ion transport regulator 4 isoform X2
FXYD domain-containing ion transport regulator 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
RasGEF domain family member 1A, transcript variant X2
RasGEF domain family member 1A, transcript variant X3
RasGEF domain family member 1A, transcript variant X1
ras-GEF domain-containing family member 1A isoform X1
RasGEF domain family member 1A, transcript variant X4
RasGEF domain family member 1A, transcript variant X5
ras-GEF domain-containing family member 1A isoform X2
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X6
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X1
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X4
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X2
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X3
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X5
chondroitin sulfate N-acetylgalactosaminyltransferase 2 isoform X2
chondroitin sulfate N-acetylgalactosaminyltransferase 2 isoform X1
proto-oncogene tyrosine-protein kinase receptor Ret
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
BMS1 ribosome biogenesis factor, transcript variant X3
BMS1 ribosome biogenesis factor, transcript variant X1
BMS1 ribosome biogenesis factor, transcript variant X2
ribosome biogenesis protein BMS1 homolog
zinc finger protein 248, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 248, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 25, transcript variant X6
zinc finger protein 25, transcript variant X5
zinc finger protein 25, transcript variant X1
zinc finger protein 25, transcript variant X7
zinc finger protein 25, transcript variant X4
zinc finger protein 25, transcript variant X2
zinc finger protein 25, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
ankyrin repeat domain-containing protein 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat domain-containing protein 26, transcript variant X2
ankyrin repeat domain-containing protein 26 isoform X1
ankyrin repeat domain-containing protein 26 isoform X2
calcium voltage-gated channel subunit alpha1 C, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
calcium voltage-gated channel subunit alpha1 C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium voltage-gated channel subunit alpha1 C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium voltage-gated channel subunit alpha1 C, transcript variant X3
calcium voltage-gated channel subunit alpha1 C, transcript variant X1
voltage-dependent L-type calcium channel subunit alpha-1C isoform X6
voltage-dependent L-type calcium channel subunit alpha-1C isoform X2
voltage-dependent L-type calcium channel subunit alpha-1C isoform X4
voltage-dependent L-type calcium channel subunit alpha-1C isoform X3
voltage-dependent L-type calcium channel subunit alpha-1C isoform X1
calcium voltage-gated channel subunit alpha1 C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
voltage-dependent L-type calcium channel subunit alpha-1C isoform X5
decapping mRNA 1B, transcript variant X1
decapping mRNA 1B, transcript variant X2
decapping mRNA 1B, transcript variant X3
calcium voltage-gated channel auxiliary subunit alpha2delta 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
voltage-dependent calcium channel subunit alpha-2/delta-4
leucine rich repeats and transmembrane domains 2, transcript variant X8
leucine rich repeats and transmembrane domains 2, transcript variant X6
leucine rich repeats and transmembrane domains 2, transcript variant X5
leucine rich repeats and transmembrane domains 2, transcript variant X7
leucine rich repeats and transmembrane domains 2, transcript variant X4
leucine rich repeats and transmembrane domains 2, transcript variant X1
leucine rich repeats and transmembrane domains 2, transcript variant X2
leucine rich repeats and transmembrane domains 2, transcript variant X11
leucine rich repeats and transmembrane domains 2, transcript variant X3
leucine rich repeats and transmembrane domains 2, transcript variant X10
leucine rich repeats and transmembrane domains 2, transcript variant X9
leucine-rich repeat and transmembrane domain-containing protein 2
5'(3')-deoxyribonucleotidase, cytosolic type-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Wnt family member 5B, transcript variant X3
Wnt family member 5B, transcript variant X1
Wnt family member 5B, transcript variant X2
F-box and leucine rich repeat protein 14, transcript variant X4
F-box and leucine rich repeat protein 14, transcript variant X1
F-box and leucine rich repeat protein 14, transcript variant X2
F-box and leucine rich repeat protein 14, transcript variant X3
ELKS/RAB6-interacting/CAST family member 1, transcript variant X4
ELKS/RAB6-interacting/CAST family member 1, transcript variant X2
ELKS/RAB6-interacting/CAST family member 1, transcript variant X1
ELKS/RAB6-interacting/CAST family member 1, transcript variant X6
ELKS/RAB6-interacting/CAST family member 1, transcript variant X5
ELKS/RAB6-interacting/CAST family member 1, transcript variant X3
ELKS/Rab6-interacting/CAST family member 1 isoform X6
ELKS/Rab6-interacting/CAST family member 1 isoform X4
ELKS/Rab6-interacting/CAST family member 1 isoform X5
ELKS/Rab6-interacting/CAST family member 1 isoform X3
ELKS/Rab6-interacting/CAST family member 1 isoform X2
ELKS/Rab6-interacting/CAST family member 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
RAD52 homolog, DNA repair protein, transcript variant X2
RAD52 homolog, DNA repair protein, transcript variant X3
RAD52 homolog, DNA repair protein, transcript variant X1
RAD52 homolog, DNA repair protein, transcript variant X4
DNA repair protein RAD52 homolog isoform X1
DNA repair protein RAD52 homolog isoform X3
DNA repair protein RAD52 homolog isoform X2
WNK lysine deficient protein kinase 1, transcript variant X11
WNK lysine deficient protein kinase 1, transcript variant X10
WNK lysine deficient protein kinase 1, transcript variant X14
WNK lysine deficient protein kinase 1, transcript variant X8
WNK lysine deficient protein kinase 1, transcript variant X9
WNK lysine deficient protein kinase 1, transcript variant X7
WNK lysine deficient protein kinase 1, transcript variant X6
WNK lysine deficient protein kinase 1, transcript variant X4
WNK lysine deficient protein kinase 1, transcript variant X3
WNK lysine deficient protein kinase 1, transcript variant X5
WNK lysine deficient protein kinase 1, transcript variant X2
WNK lysine deficient protein kinase 1, transcript variant X1
WNK lysine deficient protein kinase 1, transcript variant X13
WNK lysine deficient protein kinase 1, transcript variant X12
serine/threonine-protein kinase WNK1 isoform X11
serine/threonine-protein kinase WNK1 isoform X10
serine/threonine-protein kinase WNK1 isoform X14
serine/threonine-protein kinase WNK1 isoform X8
serine/threonine-protein kinase WNK1 isoform X9
serine/threonine-protein kinase WNK1 isoform X7
serine/threonine-protein kinase WNK1 isoform X6
serine/threonine-protein kinase WNK1 isoform X4
serine/threonine-protein kinase WNK1 isoform X3
serine/threonine-protein kinase WNK1 isoform X5
serine/threonine-protein kinase WNK1 isoform X2
serine/threonine-protein kinase WNK1 isoform X1
serine/threonine-protein kinase WNK1 isoform X13
serine/threonine-protein kinase WNK1 isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 35% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
beta-1,4-N-acetyl-galactosaminyltransferase 3
beta-1,4-N-acetylgalactosaminyltransferase 3
coiled-coil domain containing 77, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain containing 77, transcript variant X1
coiled-coil domain containing 77, transcript variant X3
coiled-coil domain containing 77, transcript variant X5
coiled-coil domain containing 77, transcript variant X4
coiled-coil domain-containing protein 77 isoform X1
coiled-coil domain-containing protein 77 isoform X2
coiled-coil domain-containing protein 77 isoform X3
coiled-coil domain-containing protein 77 isoform X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
LOW QUALITY PROTEIN: lysine-specific demethylase 5A
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
zinc finger CCHC-type and RNA-binding motif-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
haloacid dehalogenase like hydrolase domain containing 5
haloacid dehalogenase-like hydrolase domain-containing 5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: proteasome maturation protein-like
cat eye syndrome critical region protein 2 homolog, transcript variant X1
cat eye syndrome critical region protein 2 homolog isoform X1
cat eye syndrome critical region protein 2 homolog, transcript variant X2
cat eye syndrome critical region protein 2 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BH3 interacting domain death agonist, transcript variant X3
BH3 interacting domain death agonist, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
BH3 interacting domain death agonist, transcript variant X2
BH3-interacting domain death agonist isoform X2
BH3-interacting domain death agonist isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00056
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X1
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X2
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
peroxisomal biogenesis factor 26, transcript variant X3
peroxisomal biogenesis factor 26, transcript variant X4
peroxisomal biogenesis factor 26, transcript variant X1
peroxisomal biogenesis factor 26, transcript variant X2
peroxisome assembly protein 26 isoform X1
peroxisome assembly protein 26 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin specific peptidase 18, transcript variant X1
ubiquitin specific peptidase 18, transcript variant X3
ubiquitin specific peptidase 18, transcript variant X4
ubiquitin specific peptidase 18, transcript variant X2
ubl carboxyl-terminal hydrolase 18 isoform X3
ubl carboxyl-terminal hydrolase 18 isoform X1
ubl carboxyl-terminal hydrolase 18 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 6 member 13, transcript variant X1
solute carrier family 6 member 13, transcript variant X4
solute carrier family 6 member 13, transcript variant X3
solute carrier family 6 member 13, transcript variant X5
solute carrier family 6 member 13, transcript variant X2
sodium- and chloride-dependent GABA transporter 2 isoform X1
sodium- and chloride-dependent GABA transporter 2 isoform X3
sodium- and chloride-dependent GABA transporter 2 isoform X2
sodium- and chloride-dependent GABA transporter 2 isoform X4
solute carrier family 6 member 12, transcript variant X4
solute carrier family 6 member 12, transcript variant X3
solute carrier family 6 member 12, transcript variant X2
solute carrier family 6 member 12, transcript variant X1
solute carrier family 6 member 12, transcript variant X5
solute carrier family 6 member 12, transcript variant X9
sodium- and chloride-dependent betaine transporter isoform X2
solute carrier family 6 member 12, transcript variant X6
solute carrier family 6 member 12, transcript variant X7
solute carrier family 6 member 12, transcript variant X8
sodium- and chloride-dependent betaine transporter isoform X1
IQ motif and Sec7 domain ArfGEF 3, transcript variant X1
IQ motif and Sec7 domain ArfGEF 3, transcript variant X2
IQ motif and SEC7 domain-containing protein 3 isoform X1
IQ motif and SEC7 domain-containing protein 3 isoform X2
IQ motif and Sec7 domain ArfGEF 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
IQ motif and Sec7 domain ArfGEF 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 2% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
mannose-6-phosphate receptor, cation dependent
cation-dependent mannose-6-phosphate receptor
polyhomeotic homolog 1, transcript variant X6
polyhomeotic homolog 1, transcript variant X5
polyhomeotic homolog 1, transcript variant X3
polyhomeotic homolog 1, transcript variant X4
polyhomeotic homolog 1, transcript variant X1
polyhomeotic homolog 1, transcript variant X2
polyhomeotic homolog 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
ribosomal modification protein rimK like family member B, transcript variant X4
ribosomal modification protein rimK like family member B, transcript variant X1
beta-citrylglutamate synthase B isoform X3
ribosomal modification protein rimK like family member B, transcript variant X3
ribosomal modification protein rimK like family member B, transcript variant X5
beta-citrylglutamate synthase B isoform X4
ribosomal modification protein rimK like family member B, transcript variant X2
beta-citrylglutamate synthase B isoform X1
beta-citrylglutamate synthase B isoform X2
apolipoprotein B mRNA editing enzyme catalytic subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123455742, transcript variant X1
uncharacterized LOC123455742, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
endoplasmic reticulum lectin 1, transcript variant X1
endoplasmic reticulum lectin 1 isoform X1
endoplasmic reticulum lectin 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
endoplasmic reticulum lectin 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
endoplasmic reticulum lectin 1 isoform X2
endoplasmic reticulum lectin 1 isoform X3
endoplasmic reticulum lectin 1, transcript variant X4
endoplasmic reticulum lectin 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
G protein-coupled receptor 75, transcript variant X1
G protein-coupled receptor 75, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 171 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and SOCS box containing 3, transcript variant X3
ankyrin repeat and SOCS box containing 3, transcript variant X4
ChaC glutathione specific gamma-glutamylcyclotransferase 2, transcript variant X2
ChaC glutathione specific gamma-glutamylcyclotransferase 2, transcript variant X1
glutathione-specific gamma-glutamylcyclotransferase 2 isoform X2
glutathione-specific gamma-glutamylcyclotransferase 2 isoform X1
ankyrin repeat and SOCS box containing 3, transcript variant X5
ankyrin repeat and SOCS box containing 3, transcript variant X1
ankyrin repeat and SOCS box containing 3, transcript variant X6
ankyrin repeat and SOCS box containing 3, transcript variant X2
ankyrin repeat and SOCS box containing 3, transcript variant X7
ankyrin repeat and SOCS box protein 3 isoform X1
ankyrin repeat and SOCS box protein 3 isoform X2
ankyrin repeat and SOCS box protein 3 isoform X5
ankyrin repeat and SOCS box protein 3 isoform X4
ankyrin repeat and SOCS box protein 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sterol O-acyltransferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
follicle stimulating hormone receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins
follicle stimulating hormone receptor, transcript variant X2
follicle-stimulating hormone receptor isoform X1
follicle-stimulating hormone receptor isoform X2
luteinizing hormone/choriogonadotropin receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
lutropin-choriogonadotropic hormone receptor
general transcription factor IIA subunit 1 like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 21
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium two pore domain channel subfamily K member 12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit, transcript variant X2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit, transcript variant X1
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit, transcript variant X3
multiple coagulation factor deficiency protein 2 isoform X1
multiple coagulation factor deficiency protein 2 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: suppressor of cytokine signaling 5
COORDINATES: nucleotide motif:Rfam:12.0:RF00561
CXXC repeat containing interactor of PDZ3 domain, transcript variant X1
CXXC repeat containing interactor of PDZ3 domain, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class F
phosphatidylinositol-glycan biosynthesis class F protein
endothelial PAS domain protein 1, transcript variant X2
endothelial PAS domain protein 1, transcript variant X1
endothelial PAS domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65% coverage of the annotated genomic feature by RNAseq alignments
S1 RNA binding domain 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
S1 RNA binding domain 1, transcript variant X2
S1 RNA-binding domain-containing protein 1 isoform X1
S1 RNA-binding domain-containing protein 1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
prolyl endopeptidase like, transcript variant X1
prolyl endopeptidase like, transcript variant X2
prolyl endopeptidase like, transcript variant X3
neutral and basic amino acid transport protein rBAT
protein phosphatase, Mg2+/Mn2+ dependent 1B, transcript variant X2
protein phosphatase, Mg2+/Mn2+ dependent 1B, transcript variant X3
protein phosphatase, Mg2+/Mn2+ dependent 1B, transcript variant X1
leucine rich pentatricopeptide repeat containing, transcript variant X2
leucine rich pentatricopeptide repeat containing, transcript variant X1
leucine-rich PPR motif-containing protein, mitochondrial isoform X2
leucine-rich PPR motif-containing protein, mitochondrial isoform X1
ATP binding cassette subfamily G member 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
ATP binding cassette subfamily G member 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
ATP binding cassette subfamily G member 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
ATP-binding cassette sub-family G member 8 isoform X3
ATP-binding cassette sub-family G member 8 isoform X1
ATP-binding cassette sub-family G member 8 isoform X2
ATP binding cassette subfamily G member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
ATP-binding cassette sub-family G member 5
dynein cytoplasmic 2 light intermediate chain 1
cytoplasmic dynein 2 light intermediate chain 1
pleckstrin homology, MyTH4 and FERM domain containing H2, transcript variant X2
pleckstrin homology, MyTH4 and FERM domain containing H2, transcript variant X3
pleckstrin homology, MyTH4 and FERM domain containing H2, transcript variant X1
pleckstrin homology domain-containing family H member 2 isoform X1
pleckstrin homology domain-containing family H member 2 isoform X2
pleckstrin homology, MyTH4 and FERM domain containing H2, transcript variant X4
THADA armadillo repeat containing, transcript variant X1
THADA armadillo repeat containing, transcript variant X3
THADA armadillo repeat containing, transcript variant X2
thyroid adenoma-associated protein isoform X1
thyroid adenoma-associated protein isoform X2
THADA armadillo repeat containing, transcript variant X4
thyroid adenoma-associated protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
metastasis associated 1 family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
metastasis associated 1 family member 3, transcript variant X1
metastasis associated 1 family member 3, transcript variant X3
metastasis-associated protein MTA3 isoform X2
metastasis-associated protein MTA3 isoform X1
metastasis-associated protein MTA3 isoform X3
metastasis associated 1 family member 3, transcript variant X4
metastasis-associated protein MTA3 isoform X4
cytochrome c oxidase subunit 7C, mitochondrial-like
potassium voltage-gated channel modifier subfamily G member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel modifier subfamily G member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily G member 3 isoform X1
potassium voltage-gated channel subfamily G member 3 isoform X2
cytochrome c oxidase subunit 7A-related protein, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
echinoderm microtubule-associated protein-like 4 isoform X2
echinoderm microtubule-associated protein-like 4 isoform X1
protein kinase domain containing, cytoplasmic, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein kinase domain containing, cytoplasmic, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
extracellular tyrosine-protein kinase PKDCC isoform X2
extracellular tyrosine-protein kinase PKDCC isoform X1
solute carrier family 8 member A1, transcript variant X3
solute carrier family 8 member A1, transcript variant X4
solute carrier family 8 member A1, transcript variant X2
solute carrier family 8 member A1, transcript variant X1
solute carrier family 8 member A1, transcript variant X5
solute carrier family 8 member A1, transcript variant X6
solute carrier family 8 member A1, transcript variant X8
solute carrier family 8 member A1, transcript variant X7
solute carrier family 8 member A1, transcript variant X9
solute carrier family 8 member A1, transcript variant X11
solute carrier family 8 member A1, transcript variant X13
solute carrier family 8 member A1, transcript variant X14
solute carrier family 8 member A1, transcript variant X16
solute carrier family 8 member A1, transcript variant X10
solute carrier family 8 member A1, transcript variant X18
solute carrier family 8 member A1, transcript variant X12
solute carrier family 8 member A1, transcript variant X20
solute carrier family 8 member A1, transcript variant X15
solute carrier family 8 member A1, transcript variant X17
solute carrier family 8 member A1, transcript variant X19
solute carrier family 8 member A1, transcript variant X21
THUMP domain containing 2, transcript variant X2
THUMP domain containing 2, transcript variant X1
THUMP domain-containing protein 2 isoform X2
THUMP domain-containing protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
mitogen-activated protein kinase kinase kinase kinase 3, transcript variant X1
mitogen-activated protein kinase kinase kinase kinase 3, transcript variant X2
mitogen-activated protein kinase kinase kinase kinase 3 isoform X1
mitogen-activated protein kinase kinase kinase kinase 3 isoform X2
mitogen-activated protein kinase kinase kinase kinase 3, transcript variant X3
mitogen-activated protein kinase kinase kinase kinase 3 isoform X3
mitogen-activated protein kinase kinase kinase kinase 3, transcript variant X4
mitogen-activated protein kinase kinase kinase kinase 3 isoform X4
cyclin dependent kinase like 4, transcript variant X1
cyclin dependent kinase like 4, transcript variant X3
cyclin dependent kinase like 4, transcript variant X4
cyclin dependent kinase like 4, transcript variant X2
cyclin-dependent kinase-like 4 isoform X1
cyclin-dependent kinase-like 4 isoform X3
cyclin-dependent kinase-like 4 isoform X4
cyclin-dependent kinase-like 4 isoform X2
atlastin GTPase 2, transcript variant X2
atlastin GTPase 2, transcript variant X1
atlastin GTPase 2, transcript variant X5
atlastin GTPase 2, transcript variant X3
atlastin GTPase 2, transcript variant X4
regulator of microtubule dynamics 2, transcript variant X4
regulator of microtubule dynamics 2, transcript variant X3
regulator of microtubule dynamics 2, transcript variant X5
regulator of microtubule dynamics 2, transcript variant X7
regulator of microtubule dynamics 2, transcript variant X2
regulator of microtubule dynamics 2, transcript variant X6
regulator of microtubule dynamics protein 2 isoform X4
regulator of microtubule dynamics protein 2 isoform X2
regulator of microtubule dynamics protein 2 isoform X3
regulator of microtubule dynamics 2, transcript variant X1
regulator of microtubule dynamics protein 2 isoform X1
CDC42 effector protein 3, transcript variant X2
CDC42 effector protein 3, transcript variant X1
protein kinase D3, transcript variant X2
protein kinase D3, transcript variant X1
serine/threonine-protein kinase D3 isoform X1
protein kinase D3, transcript variant X3
serine/threonine-protein kinase D3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
NADH:ubiquinone oxidoreductase complex assembly factor 7
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein arginine methyltransferase NDUFAF7, mitochondrial
CCAAT enhancer binding protein zeta, transcript variant X1
CCAAT enhancer binding protein zeta, transcript variant X2
CCAAT/enhancer-binding protein zeta isoform X1
CCAAT/enhancer-binding protein zeta isoform X2
CEBPZ opposite strand, transcript variant X3
CEBPZ opposite strand, transcript variant X1
CEBPZ opposite strand, transcript variant X2
eukaryotic translation initiation factor 2 alpha kinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
eukaryotic translation initiation factor 2 alpha kinase 2, transcript variant X2
interferon-induced, double-stranded RNA-activated protein kinase isoform X1
interferon-induced, double-stranded RNA-activated protein kinase isoform X2
G-patch domain containing 11, transcript variant X1
G-patch domain containing 11, transcript variant X5
G-patch domain containing 11, transcript variant X3
G-patch domain containing 11, transcript variant X2
G-patch domain containing 11, transcript variant X4
fasciculation and elongation protein zeta 2
fasciculation and elongation protein zeta-2
cysteine rich transmembrane BMP regulator 1
family with sequence similarity 98 member A
RAS guanyl releasing protein 3, transcript variant X6
RAS guanyl releasing protein 3, transcript variant X4
RAS guanyl releasing protein 3, transcript variant X3
RAS guanyl releasing protein 3, transcript variant X1
RAS guanyl releasing protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAS guanyl releasing protein 3, transcript variant X2
ras guanyl-releasing protein 3 isoform X4
ras guanyl-releasing protein 3 isoform X2
ras guanyl-releasing protein 3 isoform X1
ras guanyl-releasing protein 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, transcript variant X1
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
transmembrane protein 17, transcript variant X1
transmembrane protein 17, transcript variant X2
EH domain binding protein 1, transcript variant X4
EH domain binding protein 1, transcript variant X2
EH domain binding protein 1, transcript variant X3
EH domain binding protein 1, transcript variant X1
EH domain binding protein 1, transcript variant X7
EH domain binding protein 1, transcript variant X5
EH domain binding protein 1, transcript variant X6
EH domain binding protein 1, transcript variant X9
EH domain binding protein 1, transcript variant X8
orthodenticle homeobox 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
orthodenticle homeobox 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD repeat containing planar cell polarity effector, transcript variant X3
WD repeat containing planar cell polarity effector, transcript variant X2
WD repeat containing planar cell polarity effector, transcript variant X1
WD repeat containing planar cell polarity effector, transcript variant X4
WD repeat containing planar cell polarity effector, transcript variant X5
WD repeat-containing and planar cell polarity effector protein fritz homolog isoform X3
WD repeat-containing and planar cell polarity effector protein fritz homolog isoform X2
WD repeat-containing and planar cell polarity effector protein fritz homolog isoform X1
WD repeat-containing and planar cell polarity effector protein fritz homolog isoform X4
WD repeat-containing and planar cell polarity effector protein fritz homolog isoform X5
WD repeat containing planar cell polarity effector, transcript variant X6
WD repeat-containing and planar cell polarity effector protein fritz homolog isoform X6
malate dehydrogenase 1, transcript variant X1
malate dehydrogenase, cytoplasmic isoform X1
malate dehydrogenase 1, transcript variant X2
malate dehydrogenase, cytoplasmic isoform X2
UDP-glucose pyrophosphorylase 2, transcript variant X3
UDP-glucose pyrophosphorylase 2, transcript variant X1
UTP--glucose-1-phosphate uridylyltransferase isoform X1
UDP-glucose pyrophosphorylase 2, transcript variant X2
UTP--glucose-1-phosphate uridylyltransferase isoform X2
UDP-glucose pyrophosphorylase 2, transcript variant X4
UTP--glucose-1-phosphate uridylyltransferase isoform X3
VPS54 subunit of GARP complex, transcript variant X2
VPS54 subunit of GARP complex, transcript variant X1
vacuolar protein sorting-associated protein 54 isoform X2
vacuolar protein sorting-associated protein 54 isoform X1
E3 ubiquitin-protein ligase pellino homolog 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 7% coverage of the annotated genomic feature by RNAseq alignments
SERTA domain containing 2, transcript variant X2
SERTA domain containing 2, transcript variant X1
SERTA domain containing 2, transcript variant X3
SERTA domain containing 2, transcript variant X4
COORDINATES: nucleotide motif:Rfam:12.0:RF01241
sprouty related EVH1 domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sprouty-related, EVH1 domain-containing protein 2
ETAA1 activator of ATR kinase, transcript variant X1
ewing's tumor-associated antigen 1 isoform X1
ETAA1 activator of ATR kinase, transcript variant X5
ETAA1 activator of ATR kinase, transcript variant X7
ETAA1 activator of ATR kinase, transcript variant X4
ETAA1 activator of ATR kinase, transcript variant X2
ewing's tumor-associated antigen 1 isoform X2
ETAA1 activator of ATR kinase, transcript variant X3
ewing's tumor-associated antigen 1 isoform X3
ETAA1 activator of ATR kinase, transcript variant X6
ETAA1 activator of ATR kinase, transcript variant X8
ewing's tumor-associated antigen 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 3% coverage of the annotated genomic feature by RNAseq alignments
C1D nuclear receptor corepressor, transcript variant X1
C1D nuclear receptor corepressor, transcript variant X2
nuclear nucleic acid-binding protein C1D
protein phosphatase 3 regulatory subunit B, alpha
cannabinoid receptor interacting protein 1
CB1 cannabinoid receptor-interacting protein 1
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta
ADAM metallopeptidase domain 17, transcript variant X2
ADAM metallopeptidase domain 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 17 isoform X1
disintegrin and metalloproteinase domain-containing protein 17 isoform X2
ADAM metallopeptidase domain 17, transcript variant X3
ADAM metallopeptidase domain 17, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ADAM metallopeptidase domain 17, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 17 isoform X3
disintegrin and metalloproteinase domain-containing protein 17 isoform X4
isoamyl acetate hydrolyzing esterase 1 (putative), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
isoamyl acetate-hydrolyzing esterase 1 homolog isoform X1
isoamyl acetate hydrolyzing esterase 1 (putative), transcript variant X2
isoamyl acetate-hydrolyzing esterase 1 homolog isoform X2
cleavage and polyadenylation specific factor 3
cleavage and polyadenylation specificity factor subunit 3
integrin subunit beta 1 binding protein 1, transcript variant X1
integrin subunit beta 1 binding protein 1, transcript variant X2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X7
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X5
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X6
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X4
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X3
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X1
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X7
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X5
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X2
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X6
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X4
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X3
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 isoform X1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2, transcript variant X8
membrane bound O-acyltransferase domain containing 2, transcript variant X1
membrane bound O-acyltransferase domain containing 2, transcript variant X2
membrane bound O-acyltransferase domain containing 2, transcript variant X6
lysophospholipid acyltransferase 2 isoform X1
lysophospholipid acyltransferase 2 isoform X2
lysophospholipid acyltransferase 2 isoform X5
membrane bound O-acyltransferase domain containing 2, transcript variant X4
membrane bound O-acyltransferase domain containing 2, transcript variant X5
membrane bound O-acyltransferase domain containing 2, transcript variant X3
lysophospholipid acyltransferase 2 isoform X3
lysophospholipid acyltransferase 2 isoform X4
kinase D interacting substrate 220, transcript variant X5
kinase D interacting substrate 220, transcript variant X1
kinase D interacting substrate 220, transcript variant X3
kinase D interacting substrate 220, transcript variant X2
kinase D interacting substrate 220, transcript variant X4
kinase D interacting substrate 220, transcript variant X6
kinase D-interacting substrate of 220 kDa isoform X5
kinase D-interacting substrate of 220 kDa isoform X1
kinase D-interacting substrate of 220 kDa isoform X3
kinase D-interacting substrate of 220 kDa isoform X2
kinase D-interacting substrate of 220 kDa isoform X4
kinase D-interacting substrate of 220 kDa isoform X6
heterogeneous nuclear ribonucleoprotein L like
heterogeneous nuclear ribonucleoprotein L-like
serine and arginine rich splicing factor 7, transcript variant X8
serine and arginine rich splicing factor 7, transcript variant X5
serine and arginine rich splicing factor 7, transcript variant X7
serine and arginine rich splicing factor 7, transcript variant X3
serine and arginine rich splicing factor 7, transcript variant X6
serine and arginine rich splicing factor 7, transcript variant X2
serine and arginine rich splicing factor 7, transcript variant X4
serine and arginine rich splicing factor 7, transcript variant X1
serine/arginine-rich splicing factor 7 isoform X8
serine/arginine-rich splicing factor 7 isoform X5
serine/arginine-rich splicing factor 7 isoform X7
serine/arginine-rich splicing factor 7 isoform X3
serine/arginine-rich splicing factor 7 isoform X6
serine/arginine-rich splicing factor 7 isoform X2
serine/arginine-rich splicing factor 7 isoform X4
serine/arginine-rich splicing factor 7 isoform X1
tetratricopeptide repeat protein 39B-like
gem nuclear organelle associated protein 6, transcript variant X2
gem nuclear organelle associated protein 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
DExH-box helicase 57, transcript variant X4
DExH-box helicase 57, transcript variant X1
DExH-box helicase 57, transcript variant X3
DExH-box helicase 57, transcript variant X2
DExH-box helicase 57, transcript variant X5
putative ATP-dependent RNA helicase DHX57 isoform X2
putative ATP-dependent RNA helicase DHX57 isoform X1
putative ATP-dependent RNA helicase DHX57 isoform X3
Rho guanine nucleotide exchange factor 33
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
SOS Ras/Rac guanine nucleotide exchange factor 1, transcript variant X3
SOS Ras/Rac guanine nucleotide exchange factor 1, transcript variant X4
SOS Ras/Rac guanine nucleotide exchange factor 1, transcript variant X2
SOS Ras/Rac guanine nucleotide exchange factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments